"'There will be a lot of angry consumers, a lot of angry researchers -- a lot of angry people in general saying why did it take so long to take Vioxx off the market,' Mamdani says. 'But to make a big decision about a drug that affects so many people's lives, and with so much money at stake -- $2.6 billion -- you do need more information. When we make decisions like this, we need lots of evidence from many directions to say something really is going on. Should that have occurred faster? Yes. But much faster? I am not so sure.'" [Web MD]
. . . And with so much money at stake?
